HomeSearchActa Materia Medica

Acta Materia Medica

Compuscript Ltd · Ireland · Est. 2022

ISSN2737-7946
SJR Q1Scopus / SJRDOAJOpen Access
40
/ 100
Medium Risk
Score Breakdown
Scopus Q1+25
DOAJ Verified+15
Total40
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗
SJR Score
1.551
H-Index
20
CiteScore
View ↗
Scopus metric · on the journal’s page
Total Works
157
Total Citations
1,515
2yr Mean Citedness
2.94
Free JIF alternative

Aims & Scope

Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but are not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management. Coverage includes: •Pathophysiology of important diseases and disease vectors • Novel therapeutic strategies • Novel methodologies facilitating the search for therapies • High-throughput screening, combinatorial chemistry, parallel synthesis and library design • 3D Structures and functions of therapeutic targets • Structural biological studies of relevant ligands and targets • Discovery, design and synthesis of biologically active agents, including natural products, therapeutic macromolecules • Drug delivery • ADME/Toxicology • Advances in key compound classes and therapeutic areas • Omics in pharmaceutical sciences • Biological databases, web-based software for pharmaceutical sciences • Studies of biological activity or mode of action. • Structure-activity correlations of drugs • Development of new imaging and diagnostic tools • Computational studies the SAR of compounds, target informatics • Business strategy for pharmaceutical industry • Clinical research and trials,  meta-analysis •Management, commercial and regulatory issues in pharmaceutical R&D. • Other aspects of pharmacy and pharmaceutical sciences.

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
13
weeks to review
Average · median is 15 wks
Q1
SJR Rank
Top 25% in field

General Information

Country / RegionIreland
Primary LanguageEnglish
1st Year Published2022
Annual Volume~ 37 articles / year
StatusActive (last: 2026)
Total Publications157
OA Since2021
Visit Journal Website

Submission Info

APC Cost💎 Diamond OA — Free
Peer ReviewSingle-blind
Review Time~13 weeks
Acceptance Rate
OA LicenseCC BY
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✗ No

Think.Check.Submit Compliance

9/12 · 75%
Do you know the journal / publisher?
Compuscript Ltd
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2737-7946
Indexed in a trusted database?
Scopus, DOAJ
Peer review process documented?
Single-blind
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
No APC (Free)
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
No
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Complementary and Manual TherapyQ1
Inorganic ChemistryQ1
Molecular MedicineQ1
Occupational TherapyQ1
PathophysiologyQ1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Subject Classification

Scopus Categories

Inorganic ChemistryPathophysiologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)Molecular MedicineComplementary and Manual TherapyOccupational Therapy

Research Topics (OpenAlex)

Protein Degradation and InhibitorsNanoplatforms for cancer theranosticsUbiquitin and proteasome pathwaysComputational Drug Discovery MethodsHistone Deacetylase Inhibitors ResearchPharmacological Effects of Natural CompoundsAdvanced Drug Delivery SystemsFerroptosis and cancer prognosisAdvanced Nanomaterials in CatalysisPeptidase Inhibition and Analysis
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref